Related Experiment Video
Updated: May 3, 2026

Prostaglandin Extraction and Analysis in Caenorhabditis elegans
Published on: June 25, 2013
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma
L Chastine Bell-Parikh1, Tomomi Ide, John A Lawson
1Center for Experimental Therapeutics, University of Pennsylvania School of Medicine, 153 Johnson Pavilion, 3620 Hamilton Walk, Philadelphia, Pennsylvania 19104-6084, USA. garret@spirit.gcrc.upenn.edu
Abstract:
15-deoxy-Delta12,14-PGJ2 (15d-PGJ2) has been identified as an endogenous ligand for PPARgamma, inducing adipogenesis in vitro. Additional roles for this molecule in the propagation and resolution of inflammation, ligation of NF-kappaB, and mediation of apoptosis have been proposed. However, quantitative, physiochemical evidence for the formation of 15d-PGJ2 in vivo is lacking. We report that 15d-PGJ2 is detectable using liquid chromatography-mass spectrometry-mass spectrometry at low picomolar concentrations in the medium of 3T3-L1 preadipocytes. However, despite induction of COX-2, production of PGs, including 15d-PGJ2, does not increase during adipocyte differentiation, a process unaltered by COX inhibition. 15d-PGJ2 is detectable as a minor product of COX-2 in human urine. However, its biosynthesis is unaltered during or after COX activation in vivo by LPS. Furthermore, the biosynthesis of 15d-PGJ2 is not augmented in the joint fluid of patients with arthritis, nor is its urinary excretion increased in patients with diabetes or obesity. 15d-PGJ2 is not the endogenous mediator of PPARgamma-dependent adipocyte activation and is unaltered in clinical settings in which PPARgamma activation has been implicated.
Insights
15-deoxy-Delta12,14-PGJ2 (15d-PGJ2) is detectable in vitro but not significantly produced in vivo during adipogenesis or inflammation. This study finds 15d-PGJ2 is not the primary mediator of PPARgamma-dependent adipocyte activation.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- 15-deoxy-Delta12,14-PGJ2 (15d-PGJ2) is an endogenous PPARgamma ligand linked to adipogenesis and inflammation.
- Proposed roles include NF-kappaB ligation and apoptosis mediation.
- Quantitative in vivo evidence for 15d-PGJ2 formation is lacking.
Purpose of the Study:
- To investigate the in vivo formation and physiological relevance of 15d-PGJ2.
- To determine if 15d-PGJ2 mediates PPARgamma-dependent adipocyte activation.
- To assess 15d-PGJ2 levels in conditions associated with inflammation and metabolic disease.
Main Methods:
- Liquid chromatography-mass spectrometry-mass spectrometry (LC-MS-MS) for 15d-PGJ2 detection.
- Analysis of 15d-PGJ2 in 3T3-L1 preadipocyte cultures.
- Measurement of 15d-PGJ2 in human urine and arthritis joint fluid.
- Investigation of 15d-PGJ2 levels during COX-2 induction and LPS challenge.
Main Results:
- 15d-PGJ2 is detectable at picomolar levels in vitro but not increased during adipocyte differentiation.
- While a minor product of COX-2 in urine, its biosynthesis is not altered by LPS activation in vivo.
- 15d-PGJ2 levels are not augmented in arthritis joint fluid, diabetes, or obesity.
Conclusions:
- 15d-PGJ2 is not the endogenous mediator of PPARgamma-dependent adipocyte activation.
- Its in vivo production and levels are not significantly altered in key physiological and pathological states.
- The proposed roles of 15d-PGJ2 in inflammation and adipogenesis require further investigation regarding its in vivo significance.
More Related Videos
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
GPI Anchoring of Proteins in the ER Membrane
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
IP3/DAG Signaling Pathway
Biosynthesis in Bacteria
Biosynthesis of Nucleic Acids
Biosynthesis of Lipids

